Srb Corp Q3 2022 vs. Q4 2022 13F Holdings Comparison
Ava Hoppe | 29 April, 2023
Investors are always keen to keep track of changes in their fund holdings and understandably so. Changes in holdings can reveal a lot about the fund's investment strategy and how the market is behaving. The Srb Corp Q3 2022 vs. Q4 2022 13F Holdings Comparison provides useful information on the changes in holdings of this fund during the period. In this blog post, we will analyze the data and provide insights into what these changes might mean for investors.
Microsoft Corp - Holding Steady
Microsoft Corp is Srb Corp's largest holding, and the data shows that the fund held 1,126,467 shares in Q3 2022 and 1,128,282 shares in Q4 2022. The total value of these shares also increased from $262,354,000 to $270,584,000, representing a change of 3.1%. This suggests that Srb Corp is bullish on Microsoft Corp and has maintained its position in the company.
Merck & Co. Inc. - A Conservative Approach
Srb Corp's holdings in Merck & Co. Inc. remained fairly stable during the period, with the fund holding 1,848,806 shares in Q3 2022 and 1,848,407 shares in Q4 2022. However, the total value of these shares increased from $159,219,000 to $205,081,000, representing a change of 28.8%. This suggests that Srb Corp is bullish on Merck & Co. Inc. and has taken a conservative approach to increase its stake in the company.
CVS Health Corp - A Minor Decrease
Srb Corp's holdings in CVS Health Corp decreased slightly during the period, with the fund holding 2,134,360 shares in Q3 2022 and 2,130,282 in Q4 2022. The total value of these shares also decreased from $203,554,000 to $198,521,000, representing a change of -2.5%. This indicates that Srb Corp may be less bullish on CVS Health Corp and has reduced its stake in the company slightly.
Procter & Gamble Co - A Major Increase
Srb Corp's holdings in Procter & Gamble Co increased significantly during the period, with the fund holding 948,303 shares in Q3 2022 and 948,560 shares in Q4 2022. The total value of these shares increased from $119,723,000 to $143,763,000, representing a change of 20.1%. This suggests that Srb Corp is bullish on Procter & Gamble Co and has increased its stake in the company significantly.
Verisk Analytics Inc - A Moderate Increase
Srb Corp's holdings in Verisk Analytics Inc increased moderately during the period, with the fund holding 179,925 shares in Q3 2022 and 182,502 shares in Q4 2022. The total value of these shares increased from $30,683,000 to $32,197,000, representing a change of 4.9%. This suggests that Srb Corp is bullish on Verisk Analytics Inc and has increased its stake in the company moderately.
Conclusion
The Srb Corp Q3 2022 vs. Q4 2022 13F Holdings Comparison provides valuable insights into the changes in holdings of this fund during the period. The data shows that Srb Corp has taken a conservative approach with some holdings, while significantly increasing its stake in others. These changes may signal the fund's bullish or bearish stance on the companies that it holds. However, it's essential to note that these changes may not always reflect the overall market trend or the long-term performance of the companies. Therefore, investors should not base their investment decisions solely on this data but should instead carefully consider various other factors.
Other Posts
- Independent Investors Inc Q3 2023 vs. Q4 2023 13F Holdings Comparison
- EyeSouth Partners Affiliates With Atlantic Eye Institute, Expanding Their Premier Network of Eye Care Services
- Pinnacle Wealth Management Advisory Group, LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Unlocking Value and Navigating the Future: Agiliti's New Chapter with THL Partners
- The Rise and Fall of Holdings: Comparing Valeo Financial Advisors, LLC Q4 2022 and Q1 2023
- Q3 vs Q4 2022 13F Holdings Comparison Reveals Changes in Fund Holdings Including TOTL, PFFV, and VTI
- **Title: Navidea Biopharmaceuticals Files Form 15, Streamlining Reporting Obligations for Strategic Focus**
- Navigating Market Shifts: A Deep Dive into Fund Holdings Changes from Q4 2023 to Q1 2024
- Navigating Trends: A Comprehensive Analysis of Q4 2023 to Q1 2024 Fund Holdings Shifts
- Exploring the Winds of Change: A Deep Dive into Oak Asset Management's Latest Moves